Adam Swallow - Investigating the Use of Gastroprotectants as a Means of Preventing Iatrogenic Gastrointestinal Signs Associated With Immunosuppressive Corticosteroid Therapy. A Retrospective Study

Gastroprotectants are commonly prescribed in patients receiving immunosuppressive therapy with glucocorticoids. Presently, there is limited evidence to support such use of gastroprotectants. The objective of this study was to establish if the prophylactic use of gastroprotectants was associated with a reduced incidence of gastrointestinal signs in dogs receiving immunosuppressive doses of glucocorticoids, compared to not receiving prophylactic gastroprotectants. Read more and listen to the Q&As here.

Veterinary Evidence Today
Edinburgh, 1-3 November 2016